US Patent RE41895 Epothilone derivatives
Patent RE41895 was granted and assigned to Bristol-Myers Squibb on October, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+260 characters)
Article
Patent abstract
The present invention relates to epothilone derivatives, having the following formulain which the variables G, W, Q, X, Y, B1, B2, Z1, Z2, and R1-R7 are as defined herein, methods for the preparation of the derivatives and intermediates thereof.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Gregory D. Vite0
James A. Johnson0
Robert M. Borzilleri0
Soong-Hoon Kim0
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent RE041895 Epothilone derivatives US Patent RE41895 Epothilone derivatives
Infobox
Patent Number
RE0418950
Patent Number
RE418950
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
RE0418950
Date of Patent
October 26, 2010
0Patent Application Number
125394960
Date Filed
August 11, 2009
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent RE041895 Epothilone derivatives
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
RE041895
Date of patent
October 26, 2010
Patent application number
12539496
Date Filed
August 11, 2009
Patent primary examiner
Find more entities like US Patent RE41895 Epothilone derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
